Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

Affiliations

• ¹ Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
• ² Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
• ³ Centre for Immunobiology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
• ⁴ Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁵ Pfizer Inc, Collegeville, PA, USA.
• ⁶ Optum, Lincoln, RI, USA.
• ⁷ Pfizer Inc, Groton, CT, USA.
• ⁸ The University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA.